2025-11-13T14:14:53-05:00 2024-12-31 232657488 ROSENBERG SMITH COONEY & MIGLIORE PC 3331 STREET ROAD STE 445 BENSALEM PA 190202047 990 2024-01-01 460745339 ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC ECOG 2157893604 1818 MARKET STREET SUITE 3000 PHILADELPHIA PA 19103 DONNA MARINUCCI EXECUTIVE DIRECTOR 2157893631 2025-11-10 true PATRICK M SMITH CPA P00046795 2152457777 2025-11-10 2024 2025-03-06 01:10:19Z PETER O'DWYER MD 1818 MARKET STREET SUITE 3000 PHILADELPHIA PA 19103 53346165 false X ECOG-ACRIN.ORG X 2012 DE THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS. 7 7 126 0 45881692 43846729 6922643 9492403 7033 0 52804335 53346165 0 0 12696964 13924863 0 0 40015311 39558859 52712275 53483722 92060 -137557 19072184 15999632 12679927 9744932 6392257 6254700 X THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS. false false 39297578 FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER PATIENTS. THIS FEDERAL FUNDING AIDS ECOG- ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. IN ADDITION, THE FUNDS ARE USED TO PROMOTE COLLABORATION ACROSS A PROLIFIC SCIENTIFIC COMMUNITY AND TO CONTINUE THE STRONG ENGAGEMENT OF PATIENT ADVOCACY AT ALL LEVELS. 4848349 7409962 PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH NCI PROTOCOL. ALL FUNCTIONS ARE PERFORMED IN COMPLIANCE WITH FEDERAL, STATE AND LOCAL LAWS, WITH AN OVERARCHING GOAL OF REACHING FULL ACCRUALS TO FURTHER ADVANCE THE RESEARCH AND MEDICINE AIMED AT IMPROVING OUTCOMES FOR CANCER PATIENTS. 467523 537585 FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT SPECIFIC RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT THE PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. 1361345 1838970 OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. 1361345 1838970 45974795 true true false false false false false false false false true false false true true false true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 212 0 126 true false false false false false false false false false false false false X 7 7 false false false false false false false true true false false true true true true true true false false false X X MANAGEMENT 2157893604 1818 MARKET STREET SUITE 1100 PHILADELPHIA PA 19103 DANIEL BARBORIAK MD BOARD MEMBER X 0 0 0 AL BOWEN BENSON MD BOARD MEMBER X 0 0 0 PATRICK FLYNN MD BOARD MEMBER X 0 0 0 STANLEY M HAMILTON MD BOARD MEMBER X 0 0 0 BARRY A SIEGEL MD BOARD MEMBER X 0 0 0 MITCHELL SCHNALL MD PHD SECRETARY/TR 4.00 X X 0 0 0 PETER O'DWYER MD PRESIDENT 15.00 X X 0 0 0 DONNA MARINUCCI EXECUTIVE DI 40.00 X 304916 0 13195 JEAN MACDONALD DEPUTY EXEC 40.00 X 271847 0 36376 KENNETH ROCKWELL DIR REGULATO 40.00 X 222411 0 38976 PAMELA COGLIANO DIRECTOR OF 40.00 X 198544 0 34397 KERRY HIGGINS DIRECTOR DAT 40.00 X 214110 0 35410 1211828 158354 32 false true false COALITION OF CANCER COOPERATIVE GRPS 1818 MARKET STREET SUITE 3000 PHILADELPHIA PA 19103 SALARY SUPPORT 3518534 1 43180391 666338 43846729 CONTRACT SERVICES - COMM 8351601 8351601 SUPPORT SERVICES 603217 603217 CONTRACT SERVICES - GOVT 537585 537585 9492403 7033 7033 53346165 9499436 9779041 8154005 1625036 316962 264283 52679 2978082 2297192 680890 850778 709379 141399 1480 1480 32500 32500 678145 422849 255296 429364 200304 229060 442303 442303 344270 313939 30331 1676 1676 37039 37039 22444 22444 PATIENT/SITE PAYMENTS 18162209 18162209 SUBAWARD 15057174 15057174 SUBCONTRACTORS 2318145 6041 2312104 OPERATING LEASE EXPENSE 1247959 1247959 784151 385744 398407 53483722 45974795 7508927 0 1130943 2239330 14071159 11068145 70463 81891 1386661 1275379 148321 111282 3651298 2498984 19072184 15999632 8379910 6590537 725932 733705 3574085 2420690 12679927 9744932 X 6313357 6117800 78900 136900 6392257 6254700 19072184 15999632 -137557 X false true X true true true X 38059421 46015823 42816877 45881692 43846729 216620542 38059421 46015823 42816877 45881692 43846729 216620542 216620542 7033 7033 216627575 29240338 1.00000 1.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 246726 143272 103454 1132516 1124688 7828 7419 7419 111282 OPERATING LEASE RIGHT OF USE ASSET 2358292 REFUNDABLE DEPOSIT 140692 2498984 OPERATING LEASE LIABILITY 2420690 2420690 53346165 53346165 53346165 53483722 53483722 53483722 X false false false false false false false false false DONNA MARINUCCI EXECUTIVE DIRECTOR 304916 11842 1353 318111 JEAN MACDONALD DEPUTY EXEC DIRECTOR 271847 9973 26403 308223 KENNETH ROCKWELL DIR REGULATORY AFF 222411 8498 30478 261387 PAMELA COGLIANO DIRECTOR OF PROTOCOL 198544 7768 26629 232941 KERRY HIGGINS DIRECTOR DATA MGMT 214110 8157 27253 249520 SCHEDULE J, PART III AN INDEPENDENT COMPENSATION CONSULTANT DETERMINED COMPENSATION FOR CERTAIN OTHER INDIVIDUALS AND USED THAT INFORMATION AS THE BASIS FOR DETERMINING THE EXECUTIVE DIRECTOR'S SALARY. FORM 990 - ORGANIZATION'S MISSION THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS. FORM 990, PAGE 2, PART III, LINE 4D OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. FORM 990, PAGE 6, PART VI, LINE 11B THE ACCOUNTANT PREPARES THE FORM 990, WHICH IS THEN REVIEWED BY THE DIRECTOR OF FINANCE AND THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR REVIEWS THE RETURN AND THEN DISCUSSES THE RETURN WITH THE BOARD. FORM 990, PAGE 6, PART VI, LINE 12C OMB FORM 0925-0613 IS COLLECTED ANNUALLY FROM ALL OF THE DIRECTORS, OFFICERS AND INVESTIGATORS. ALSO, AT EACH BOARD OF DIRECTORS MEETING, THE DIRECTORS ARE ASKED IF THEY HAVE ANY CONFLICT OF INTEREST. FORM 990, PAGE 6, PART VI, LINE 19 NO DOCUMENTS AVAILABLE TO THE PUBLIC